Unraveling the alteration of microbiome and metabolome features in inflammatory bowel disease through multi-omics integration analysis across cohorts
Lijun Ning(Shanghai Institute of Hematology), Jie Hong(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Muni Hu(Shanghai Jiao Tong University), Jinmei Ding(Shanghai Jiao Tong University), Zhe Cui(Shanghai Jiao Tong University), Haoyan Chen(Shanghai Jiao Tong University), Han Sun(Xuzhou Medical College), Yanru Ma(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Institute of Hematology), Yuqing Yan(Shanghai Jiao Tong University), Zhenhua Wang(University of Yamanashi), Youwei Zhang(Shanghai University), Yue Zhang(Northeast Forestry University), Xiaowen Huang(Shanghai Jiao Tong University), Tianying Tong(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Ying Zhao(Shanghai Jiao Tong University), Yilu Zhou(Shanghai Jiao Tong University)
Cited by 0
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
Roles of Chk1 in cell biology and cancer therapy
|International Journal of Cancer|2013|456
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231